Literature DB >> 18003620

Genome-wide impact of the BRG1 SWI/SNF chromatin remodeler on the transforming growth factor beta transcriptional program.

Qiaoran Xi1, Wei He, Xiang H-F Zhang, Hong-Van Le, Joan Massagué.   

Abstract

The transcription factors Smad2 and Smad3 mediate a large set of gene responses induced by the cytokine transforming growth factor beta (TGFbeta), but the extent to which their function depends on chromatin remodeling remains to be defined. We observed interactions between these two Smads and BRG1, BAF250b, BAF170, and BAF155, which are core components of the SWI/SNF chromatin-remodeling complex. Smad2 and Smad3 have similar affinity for these components in vitro, and their interactions are primarily mediated by BRG1. In vivo, however, BRG1 predominantly interacts with Smad3, and this interaction is enhanced by TGFbeta stimulation. Our results suggest that BRG1 is incorporated into transcriptional complexes that are formed by activated Smads in the nucleus, on target promoters. Using BRG1-deficient cell systems, we defined the BRG1 dependence of the TGFbeta transcriptional program genome-wide. Most TGFbeta gene responses in human epithelial cells are dependent on BRG1 function. Remarkably, BRG1 is not required for the TGFbeta-mediated induction of SMAD7 and SNON, which encode key mediators of negative feedback in this pathway. Our results provide a genome-wide scope of the participation of BRG1 in TGFbeta action and suggest a widespread yet differential involvement of BRG1 SWI/SNF remodeler in the transcriptional response of many genes to this cytokine.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18003620      PMCID: PMC2692279          DOI: 10.1074/jbc.M707479200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  71 in total

Review 1.  Mechanisms for ATP-dependent chromatin remodelling: farewell to the tuna-can octamer?

Authors:  Andrew Flaus; Tom Owen-Hughes
Journal:  Curr Opin Genet Dev       Date:  2004-04       Impact factor: 5.578

2.  Transcriptional regulation of the TGF-beta pseudoreceptor BAMBI by TGF-beta signaling.

Authors:  Takashi Sekiya; Takeaki Oda; Ken Matsuura; Tetsu Akiyama
Journal:  Biochem Biophys Res Commun       Date:  2004-07-30       Impact factor: 3.575

3.  Hematopoiesis controlled by distinct TIF1gamma and Smad4 branches of the TGFbeta pathway.

Authors:  Wei He; David C Dorn; Hediye Erdjument-Bromage; Paul Tempst; Malcolm A S Moore; Joan Massagué
Journal:  Cell       Date:  2006-06-02       Impact factor: 41.582

4.  Defective repression of c-myc in breast cancer cells: A loss at the core of the transforming growth factor beta growth arrest program.

Authors:  C R Chen; Y Kang; J Massagué
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

5.  Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene.

Authors:  S Dennler; S Itoh; D Vivien; P ten Dijke; S Huet; J M Gauthier
Journal:  EMBO J       Date:  1998-06-01       Impact factor: 11.598

6.  Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway.

Authors:  Yibin Kang; Wei He; Shaun Tulley; Gaorav P Gupta; Inna Serganova; Chang-Rung Chen; Katia Manova-Todorova; Ronald Blasberg; William L Gerald; Joan Massagué
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-19       Impact factor: 11.205

7.  Chromatin remodeling factors and BRM/BRG1 expression as prognostic indicators in non-small cell lung cancer.

Authors:  Junya Fukuoka; Takeshi Fujii; Joanna H Shih; Tatiana Dracheva; Daoud Meerzaman; Audrey Player; Kyeong Hong; Sharon Settnek; Ajay Gupta; Kenneth Buetow; Stephen Hewitt; William D Travis; Jin Jen
Journal:  Clin Cancer Res       Date:  2004-07-01       Impact factor: 12.531

8.  Human type 2 phosphatidic acid phosphohydrolases. Substrate specificity of the type 2a, 2b, and 2c enzymes and cell surface activity of the 2a isoform.

Authors:  R Roberts; V A Sciorra; A J Morris
Journal:  J Biol Chem       Date:  1998-08-21       Impact factor: 5.157

9.  Altered control of cellular proliferation in the absence of mammalian brahma (SNF2alpha).

Authors:  J C Reyes; J Barra; C Muchardt; A Camus; C Babinet; M Yaniv
Journal:  EMBO J       Date:  1998-12-01       Impact factor: 11.598

10.  Loss of BRG1/BRM in human lung cancer cell lines and primary lung cancers: correlation with poor prognosis.

Authors:  David N Reisman; Janiece Sciarrotta; Weidong Wang; William K Funkhouser; Bernard E Weissman
Journal:  Cancer Res       Date:  2003-02-01       Impact factor: 12.701

View more
  58 in total

1.  Chromatin-modifying agents for epigenetic reprogramming and endogenous neural stem cell-mediated repair in stroke.

Authors:  Irfan A Qureshi; Mark F Mehler
Journal:  Transl Stroke Res       Date:  2011-03-01       Impact factor: 6.829

2.  Distinct modes of SMAD2 chromatin binding and remodeling shape the transcriptional response to NODAL/Activin signaling.

Authors:  Davide M Coda; Tessa Gaarenstroom; Philip East; Harshil Patel; Daniel S J Miller; Anna Lobley; Nik Matthews; Aengus Stewart; Caroline S Hill
Journal:  Elife       Date:  2017-02-13       Impact factor: 8.140

3.  Constitutively active SMAD2/3 facilitates efficient transcription factor-mediated cell conversion.

Authors:  Sophia Kelaini; Andriana Margariti
Journal:  Stem Cell Investig       Date:  2018-08-22

Review 4.  Transcriptional Control by the SMADs.

Authors:  Caroline S Hill
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-10-03       Impact factor: 10.005

Review 5.  Signaling Receptors for TGF-β Family Members.

Authors:  Carl-Henrik Heldin; Aristidis Moustakas
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-08-01       Impact factor: 10.005

6.  Chromatin immunoprecipitation on microarray analysis of Smad2/3 binding sites reveals roles of ETS1 and TFAP2A in transforming growth factor beta signaling.

Authors:  Daizo Koinuma; Shuichi Tsutsumi; Naoko Kamimura; Hirokazu Taniguchi; Keiji Miyazawa; Makoto Sunamura; Takeshi Imamura; Kohei Miyazono; Hiroyuki Aburatani
Journal:  Mol Cell Biol       Date:  2008-10-27       Impact factor: 4.272

7.  Baf60c is a component of the neural progenitor-specific BAF complex in developing retina.

Authors:  Deepak A Lamba; Susan Hayes; Mike O Karl; Thomas Reh
Journal:  Dev Dyn       Date:  2008-10       Impact factor: 3.780

8.  Epigenetic mechanisms modulate thyroid transcription factor 1-mediated transcription of the surfactant protein B gene.

Authors:  Yuxia Cao; Tiffany Vo; Guetchyn Millien; Jean-Bosco Tagne; Darrell Kotton; Robert J Mason; Mary C Williams; Maria I Ramirez
Journal:  J Biol Chem       Date:  2009-11-10       Impact factor: 5.157

9.  Mammalian SWI/SNF--a subunit BAF250/ARID1 is an E3 ubiquitin ligase that targets histone H2B.

Authors:  Xuan Shirley Li; Patrick Trojer; Tatsushi Matsumura; Jessica E Treisman; Naoko Tanese
Journal:  Mol Cell Biol       Date:  2010-01-19       Impact factor: 4.272

10.  Targeting CDK9 Reactivates Epigenetically Silenced Genes in Cancer.

Authors:  Hanghang Zhang; Somnath Pandey; Meghan Travers; Hongxing Sun; George Morton; Jozef Madzo; Woonbok Chung; Jittasak Khowsathit; Oscar Perez-Leal; Carlos A Barrero; Carmen Merali; Yasuyuki Okamoto; Takahiro Sato; Joshua Pan; Judit Garriga; Natarajan V Bhanu; Johayra Simithy; Bela Patel; Jian Huang; Noël J-M Raynal; Benjamin A Garcia; Marlene A Jacobson; Cigall Kadoch; Salim Merali; Yi Zhang; Wayne Childers; Magid Abou-Gharbia; John Karanicolas; Stephen B Baylin; Cynthia A Zahnow; Jaroslav Jelinek; Xavier Graña; Jean-Pierre J Issa
Journal:  Cell       Date:  2018-10-25       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.